GoodRx (GDRX) Short Interest Ratio & Short Volume $4.90 +0.61 (+14.22%) (As of 11/22/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends GoodRx Short Interest DataGoodRx (GDRX) has a short interest of 8.69 million shares, representing 10.71% of the float (the number of shares available for trading by the public). This marks a -3.01% decrease in short interest from the previous month. The short interest ratio (days to cover) is 6.8, indicating that it would take 6.8 days of the average trading volume of 1.45 million shares to cover all short positions.Current Short Interest8,690,000 sharesPrevious Short Interest8,960,000 sharesChange Vs. Previous Month-3.01%Dollar Volume Sold Short$53.18 millionShort Interest Ratio6.8 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares381,140,000 sharesFloat Size81,160,000 sharesShort Percent of Float10.71%Today's Trading Volume2,976,553 sharesAverage Trading Volume1,452,888 sharesToday's Volume Vs. Average205% Short Selling GoodRx? Sign up to receive the latest short interest report for GoodRx and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGDRX Short Interest Over TimeGDRX Days to Cover Over TimeGDRX Percentage of Float Shorted Over Time Ad Behind the Markets📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Take these 4 steps to protect your retirement here >>> GoodRx Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/20248,690,000 shares $53.18 million -3.0%10.7%6.8 $6.12 10/15/20248,960,000 shares $62.36 million -0.8%11.0%6.9 $6.96 9/30/20249,030,000 shares $62.67 million +0.9%11.1%6.6 $6.94 9/15/20248,950,000 shares $69.36 million -0.9%11.0%6.6 $7.75 8/31/20249,030,000 shares $71.34 million +10.0%11.1%6.6 $7.90 8/15/20248,210,000 shares $56.81 million +4.5%10.2%6 $6.92 Get the Latest News and Ratings for GDRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for GoodRx and its competitors with MarketBeat's FREE daily newsletter. 7/31/20247,860,000 shares $71.13 million -5.9%10.2%5.2 $9.05 7/15/20248,350,000 shares $69.39 million No Change10.8%6.5 $8.31 2/29/20249,690,000 shares $75.49 million -0.3%12.6%5.7 $7.79 2/15/20249,720,000 shares $65.42 million -0.2%12.8%6.3 $6.73 1/31/20249,740,000 shares $58.44 million +1.5%13.1%5.5 $6.00 1/15/20249,600,000 shares $63.74 million +18.1%12.9%5.3 $6.64 12/31/20238,130,000 shares $54.47 million +2.9%10.9%5.2 $6.70 12/15/20237,900,000 shares $50.01 million -11.2%10.6%5.6 $6.33 11/30/20238,900,000 shares $53.31 million +10.2%12.2%6.6 $5.99 11/15/20238,080,000 shares $42.66 million +11.8%13.5%6.4 $5.28 10/31/20237,230,000 shares $35.64 million -13.3%10.8%5.6 $4.93 10/15/20238,340,000 shares $44.29 million +5.6%11.2%4.8 $5.31 9/30/20237,900,000 shares $44.48 million +1.7%10.6%3.9 $5.63 9/15/20237,770,000 shares $46.62 million +12.0%10.5%3.9 $6.00 8/31/20236,940,000 shares $45.32 million +53.9%9.4%3.5 $6.53 8/15/20234,510,000 shares $33.28 million -13.1%6.1%2.3 $7.38 7/31/20235,190,000 shares $47.96 million +2.6%7.4%2.9 $9.24 7/15/20235,060,000 shares $37.75 million +1.2%7.7%3.9 $7.46 6/30/20235,000,000 shares $27.60 million -4.0%7.6%4.6 $5.52 6/15/20235,210,000 shares $30.11 million +7.2%8.0%4.6 $5.78 5/31/20234,860,000 shares $26.39 million -1.6%7.4%3.4 $5.43 5/15/20234,940,000 shares $25.69 million No Change7.5%3.1 $5.20 10/31/202211,900,000 shares $63.90 million -2.5%N/A3.7 $5.37 10/15/202212,200,000 shares $57.95 million -3.2%N/A3.6 $4.75 9/30/202212,600,000 shares $58.84 million +6.4%18.8%3.8 $4.67 9/15/202211,840,000 shares $77.08 million -12.2%17.6%3.6 $6.51 8/31/202213,490,000 shares $82.29 million -10.3%20.2%4.2 $6.10 8/15/202215,040,000 shares $108.44 million -19.3%22.4%4.8 $7.21 7/31/202218,640,000 shares $116.13 million -0.2%28.9%6.9 $6.23 7/15/202218,670,000 shares $121.92 million +1.4%28.9%8.5 $6.53 6/30/202218,420,000 shares $109.05 million +2.3%28.5%8.4 $5.92 6/15/202218,010,000 shares $112.74 million +26.4%27.9%8.2 $6.26 5/31/202214,250,000 shares $113.57 million +22.0%21.7%6 $7.97 5/15/202211,680,000 shares $103.95 million +11.6%17.8%3.6 $8.90This company will win the AI race (Ad)Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse. You must read this new presentation from Porter Stansberry. 4/30/202210,470,000 shares $141.87 million -8.0%15.4%3.8 $13.55 4/15/202211,380,000 shares $211.67 million +12.7%16.7%4.3 $18.60 3/31/202210,100,000 shares $195.23 million -8.6%N/A3.7 $19.33 3/15/202211,050,000 shares $166.08 million -30.9%16.5%3.9 $15.03 2/28/202215,980,000 shares $437.85 million +10.6%25.5%6.1 $27.40 2/15/202214,450,000 shares $421.65 million -6.1%23.0%9 $29.18 1/31/202215,390,000 shares $369.51 million -3.1%23.2%9.4 $24.01 1/15/202215,880,000 shares $426.38 million +3.9%N/A0 $26.85 12/31/202115,290,000 shares $499.68 million +2.1%22.4%10.3 $32.68 12/15/202114,970,000 shares $562.42 million +3.7%21.9%10.3 $37.57 11/30/202114,430,000 shares $576.05 million -1.8%21.3%10.1 $39.92 11/15/202114,690,000 shares $588.19 million -10.4%21.9%9.9 $40.04 10/29/202116,400,000 shares $731.44 million -1.2%26.0%10.2 $44.60 10/15/202116,590,000 shares $703.75 million +7.2%26.3%10.1 $42.42 9/30/202115,470,000 shares $634.58 million -3.0%24.5%9.1 $41.02 9/15/202115,950,000 shares $706.43 million -2.2%25.5%9.1 $44.29 8/31/202116,310,000 shares $620.11 million -14.6%26.5%9.5 $38.02 8/13/202119,100,000 shares $708.23 million +18.5%30.9%10.7 $37.08 7/30/202116,120,000 shares $516.97 million -1.8%28.1%8.2 $32.07 7/15/202116,420,000 shares $491.61 million +0.1%28.7%8.4 $29.94 6/30/202116,410,000 shares $590.92 million -2.7%28.7%8.6 $36.01 6/15/202116,870,000 shares $631.78 million -5.2%29.5%8.1 $37.45 5/28/202117,790,000 shares $660.19 million +8.1%31.1%7.4 $37.11 5/14/202116,460,000 shares $465.32 million +12.4%28.3%6.9 $28.27 4/30/202114,640,000 shares $592.63 million +12.5%25.6%7.1 $40.48 4/15/202113,010,000 shares $490.09 million +1.1%24.9%5.9 $37.67 3/31/202112,870,000 shares $488.29 million +10.3%27.1%5.8 $37.94 3/15/202111,670,000 shares $455.71 million +20.7%24.8%5.5 $39.05 2/26/20219,670,000 shares $440.47 million +6.4%29.7%4.9 $45.55 2/12/20219,090,000 shares $491.59 million -10.0%27.7%3.8 $54.08 1/29/202110,100,000 shares $487.22 million -21.2%28.4%3.4 $48.24 1/15/202112,810,000 shares $566.97 million No Change36.0%4.4 $44.26 GDRX Short Interest - Frequently Asked Questions What is GoodRx's current short interest? Short interest is the volume of GoodRx shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders have sold 8,690,000 shares of GDRX short. 10.71% of GoodRx's shares are currently sold short. Learn More on GoodRx's current short interest. What is a good short interest ratio for GoodRx? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GDRX shares currently have a short interest ratio of 7.0. Learn More on GoodRx's short interest ratio. Which institutional investors are shorting GoodRx? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of GoodRx: Parallax Volatility Advisers L.P., Walleye Trading LLC, and Walleye Capital LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for GoodRx? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 10.71% of GoodRx's floating shares are currently sold short. Is GoodRx's short interest increasing or decreasing? GoodRx saw a decline in short interest in the month of October. As of October 31st, there was short interest totaling 8,690,000 shares, a decline of 3.0% from the previous total of 8,960,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is GoodRx's float size? GoodRx currently has issued a total of 381,140,000 shares. Some of GoodRx's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. GoodRx currently has a public float of 81,160,000 shares. How does GoodRx's short interest compare to its competitors? 10.71% of GoodRx's shares are currently sold short. Here is how the short interest of companies compare to GoodRx: Dada Nexus Limited (0.84%), Etsy, Inc. (15.88%), Nuvei Co. (3.91%), TriNet Group, Inc. (2.99%), Alight, Inc. (8.39%), DXC Technology (3.93%), Payoneer Global Inc. (3.56%), CarGurus, Inc. (6.62%), Clarivate Plc (8.40%), ACV Auctions Inc. (5.79%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short GoodRx stock? Short selling GDRX is an investing strategy that aims to generate trading profit from GoodRx as its price is falling. GDRX shares are trading up $0.61 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against GoodRx? A short squeeze for GoodRx occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GDRX, which in turn drives the price of the stock up even further. How often is GoodRx's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GDRX, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Dada Nexus Short Squeeze Etsy Short Squeeze Nuvei Short Squeeze TriNet Group Short Squeeze Alight Short Squeeze DXC Technology Short Squeeze Payoneer Global Short Squeeze CarGurus Short Squeeze Clarivate Short Squeeze ACV Auctions Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GDRX) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GoodRx Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GoodRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GDRX Stock Alerts